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Abstract
Background: Depressive and anxiety symptoms in older adults could develop into significant health
problems with detrimental effects on quality of life and a possibly poor prognosis. Therefore, there is a
need for preventive interventions which are at once effective, acceptable and economic affordable.
Methods and design: This paper describes the design of a study evaluating "The stories we live by", a
preventive life-review group intervention, which was recently developed for adults of 55 years and over
with depressive and anxiety symptoms. Both clinical and economic effectiveness will be evaluated in a
pragmatic randomized controlled trial. The participants in the intervention condition will receive the 8-
session preventive intervention. The participants in the control condition will have access to usual care.
Clinical end-terms are depressive and anxiety symptoms, current major depressive episode, quality of life
and positive mental health post-treatment (3 months after baseline) and at follow-ups (6 and 12 months
after baseline). Additional goals of this study are to identify groups for whom the intervention is
particularly effective and to identify the therapeutic pathways that are vital in inducing clinical change. This
will be done by analyzing if treatment response is moderated by demographics, personality, past major
depressive episodes, important life events and chronically disease, and mediated by reminiscence functions,
perceived control, automatic positive thoughts and meaning in life. Finally the cost-effectiveness of the
intervention relative to care as usual will be assessed by computing incremental costs per case of
depression and anxiety avoided (cost-effectiveness) and per quality adjusted life year (QALY) (cost utility).
Discussion: It is expected that both the life-review intervention and its evaluation will contribute to the
existing body of knowledge in several ways. First, the intervention is unique in linking life-review with
narrative therapy and in its focus on specific, positive memories. Second, the evaluation is likely to answer
questions regarding the acceptability and cost-effectiveness of life-review that have not been addressed
thoroughly until now. Positive results of this study will make available a new evidence-based intervention
to improve public health among people of 55 years and over.
Trial registration: Nederlands Trial Register TC = 1860.
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Background
Clinical depression and anxiety in older adults is a signif-
icant health problem carrying a poor prognosis [1-5], with
prevalence rates reported as high as 8.8% to 23.6% [6,7]
for depressive disorders and 1.2% to 15% for anxiety dis-
orders [8].
The presence of depressive and anxiety symptoms which
do not meet the diagnostic criteria are by far the most
important risk factors of late-life depression and anxiety
[9-11]. Therefore, there is a great need to develop effective,
low-threshold preventive interventions for older people
reducing the risk to develop clinical depression and anxi-
ety. A recent meta-analysis shows that low-threshold, psy-
chological interventions for older adults with depressive
symptoms are indeed promising in preventing depressive
disorders [12].
Several psychological interventions are currently available
for reducing depressive and anxiety symptoms in older
people, including psycho-educational approaches, cogni-
tive behaviour therapy, psychodynamic therapy, and
interpersonal therapy [13-17]. However, previous inter-
ventions are associated with low uptake rates. Hence,
there is a need for interventions that are more acceptable.
Life-review is currently gaining popularity, because this
type of intervention can be specifically used in older
adults. Life-review is characterized by a structured re-eval-
uation of one's own life, on the one hand aimed at coping
with negative experiences and conflicts and on the other
hand at giving a positive meaning to life [18-20]. Life-
review's popularity could reflect the research findings that
many -though not all- older adults tend to look back on
and evaluate their lives [21], which seems to suggest that
it will be acceptable for older people and might even be
regarded as attractive. Moreover, research indicated that
life-review leads to a strong reduction of depressive symp-
toms, comparable to the effects of cognitive behaviour
therapy [22-26]. This method is probably also effective in
reducing anxiety symptoms [27,28]. Jointly, this evidence
appears to indicate that life-review is a promising venue to
offering a possibly effective preventive intervention for
older people otherwise not easily engaged in treatment for
the milder manifestations of anxiety and depression.
With regard to reminiscing styles, Webster [29] differenti-
ates among others between the functions of identity
developing, problem solving, bitterness revival, and bore-
dom reduction. The function "identity developing" uses
memories actively in developing one's identity by discov-
ering, clarifying and crystallizing important dimensions
of the sense of who one is. "Problem solving", also known
as instrumental reminiscence, refers to how memories of
past coping strategies can be reused in the present. "Bitter-
ness revival" is also about one's identity, but in a negative,
complaining way. Instead of being integrated in the sense
of who we are, negative experiences are constantly
brought up. In "boredom reduction", the main goal is to
escape from the present by romanticizing the past. Several
studies indicate that reminiscence aimed at bitterness
revival or boredom reduction is positively correlated with
depression and anxiety, and negatively with wellbeing
[30,31]. However, identity developing and problem solv-
ing are positively associated with psychological well-being
[31] and successful aging [32].
The extent to which and why people reminiscence is also
influenced by personality. Cully et al. [30] showed that
neurotic behaviour is correlated positively with bitterness
revival, boredom reduction and the overall level of remi-
niscence. This was borne out by Cappeliez and O'Rourke
[33], who found that a higher score on neuroticism pre-
dicted higher scores on total reminiscence, identity and
bitterness revival. More openness also predicted a higher
total level of reminiscence (identity). The intra-psychical
functions of reminiscence (boredom reduction, identity,
bitterness revival) appear to be well predicted by person-
ality characteristics.
Recently, life-review has become increasingly linked to
other therapeutic theories aiming at people with clinically
relevant mental distress [34]. For example, Watt and Cap-
peliez [25] developed a protocol in which life-review was
linked to cognitive theories about depression. They pro-
posed that life-review in depressive persons trigger recall
of unrealistic, negative cognitions about themselves and
life in general, and that these cognitions can be challenged
and modified by both the therapist and clients. A promis-
ing combination of theories might be created by integrat-
ing life-review with narrative therapy. After all, a central
assumption of narrative therapy is that life-stories are
essentially a process of reconstruction of autobiographical
memories [35,36]. Furthermore, narrative theory suggests
that reminiscence in depressed older adults is likely to
generate "problem-saturated" stories [37]. Characteristic
of these stories is their (selective) focus on negative mem-
ories [38] often structured as a victimic plot [39], in which
something good turns bad [40]. In contrast to cognitive
theory, narrative therapy does not look for changing
underlying cognitions on the basis of reality testing, but
invites people to explore alternative stories (reconstruc-
tions) that may express optimism, a greater sense of mas-
tery, and a fresh focus on positive experience. Different
stories may unveil new meanings, and there is no "final
truth" in those stories. At all times the individual client is
the expert who determines which constructions of reality
are meaningful [41].
We propose to integrate narrative therapy and life-review
into a new and unified approach to alleviate depressiveBMC Public Health 2009, 9:250 http://www.biomedcentral.com/1471-2458/9/250
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and anxiety symptoms in older people; "The stories we
live by" [42]. The essence of the intervention is to discover
stories about one's life that help the individual to lead a
contented life. The memories people have are considered
as both stories and social reconstructions of reality. It
invites people to dwell on the meanings of their experi-
ences and to evaluate those meanings. We expect that in
this way, people can discover answers about what they
regard as most important in their lives and which experi-
ences were most valuable, in that they can give meaning
to their lives [20]. Moreover, by looking back the coher-
ence of the own life story increases. Bearger and McAdams
[43] discovered a positive connection between the coher-
ence of life stories and psychological well-being.
The literature offers different explanations for the efficacy
of life-review in mental disorders, such as depression.
However, until now there hardly has been any empirical
evidence for the factors that moderate or mediate the
effects of life-review on mental distress. A first explanation
for the effectiveness of life-review is that depressive people
have associations which have been reinforced by negative
memories [44-46]. By consciously focusing on specific
and positively charged memories, negative memories are
likely to be pushed further to the background, while other
positive memories will be retrieved more easily. Another
explanation is that people experience a greater sense of
control over their lives when looking back [19]. People
become aware that they are much stronger than expected.
"The stories we live by" intervention was evaluated in a
pilot study [34]. The results were promising and to make
this life-review intervention available as a possibly evi-
dence-based intervention for older people, we think a log-
ical next step is to carry out a randomized controlled trial
(RCT). This paper describes the design of a RCT to assess
clinical and economic effectiveness. The understanding of
moderating and mediating effects is an important focus of
this study. Conceptually, analysis of moderators would
help to indentify subgroups for whom the intervention is
particularly (cost-)effective, whereas analysis of mediators
may shed light on how treatment effects are relayed over
various clinical pathways and have a final impact on clin-
ical endpoints [47]. Therefore, the specific hypotheses
that the RCT addresses are described below.
Our main hypothesis is that the life-review intervention
leads to a significant reduction of depressive and anxiety
symptoms, and in current major depression, and a signif-
icant improvement in quality of life and positive mental
health, compared to the no-treatment control condition.
In addition, we explore if gender, age, education level,
personality, past major depressive episodes, important
life events and chronic diseases, in combination with the
intervention, predict higher or lower effects on depressive
and anxiety symptoms, quality of life and positive mental
health.
Furthermore, we hypothesize that reminiscence func-
tions, perceived control, automatic positive thoughts and
meaning in life mediate the intervention's effects on clin-
ical endpoints.
Finally, we expect that the incremental costs per case of
depression and anxiety avoided (cost-effectiveness) and
per quality adjusted life year (QALY; cost-utility) are lower
in the intervention condition, compared to the care-as-
usual condition.
Methods and design
To evaluate the effectiveness of the life-review interven-
tion, we will carry out a pragmatic RCT and a cost-effec-
tiveness analysis (CEA). Participants will be randomly
assigned to either the 8-session preventive intervention or
the control condition; the care-as-usual condition. The
research has been approved by the METiGG, a medical-
ethics committee for research in mental health care set-
tings in the Netherlands.
Participants
An open recruitment strategy will be used, in cooperation
with Dutch regional mental health care institutions, via
advertisements in regional and national newspapers,
information booklets available at health care institutions
and general practitioners, plus a radio interview and com-
mercial. Health care professionals at these mental health
care centres (therapists, psychologists, etc.) will support
the participant recruitment and intake, and eventually
take care of organizing and offering the course at their cen-
tre. When people wish to participate, they will be invited
by the nearest mental health care centre for an interview.
In this interview, information is given about the interven-
tion and the accompanying study, and the in- and exclu-
sion criteria are examined.
The inclusion criteria are an age of 55 years or over, and
the presence of slight to moderate depressive and anxiety
symptoms. The presence of these symptoms will be meas-
ured by a score of 10 and above on the Dutch version of
the Center for Epidemiological Studies Depression Scale
(CES-D) [48] and a score of 3 and above on the Dutch ver-
sion of the anxiety scale of the Hospital and Anxiety Scale
(HADS-A) [49]. The CES-D is a 20-item self-report scale
developed to measure depressive symptoms in the com-
munity [48]. Participants will be asked to indicate how
often they experienced each symptom during the previous
week. Response categories, ranging from 0 to 3, are "rarely
or never", "some of the time", "occasionally", or "mostly
or always". Summation results in a CES-D score, rangingBMC Public Health 2009, 9:250 http://www.biomedcentral.com/1471-2458/9/250
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from 0 to 60. A score of 16 or higher is considered indica-
tive of clinically relevant depressive syndromes. The psy-
chometric properties of the scale are found to be reliable
in older populations [50], and more particularly in a sam-
ple of older Dutch people with depressive symptoms [51].
The HADS-A is a 7-item, self-report screening scale against
which respondents are asked to indicate whether they had
experienced feelings of restlessness, tenseness, or panic
during the past four weeks [49]. Items range from 0 "rarely
or never" to 3 "always or most of the time". The Dutch
translation has shown good psychometric properties in
six different groups of Dutch subjects [52]. Bjelland et al.
(2002) [53] showed that among the general population
and in somatic patients samples an optimal balance
between sensitivity and specificity was achieved when
caseness was defined by a score of 8 or above.
People will be excluded if diagnosed with full-blown
depression or having a moderate to high suicide risk
according the Dutch version of the Mini International
Neuropsychiatric Interview (MINI). [54,55], a short diag-
nostic psychiatric interview to assess DSM-IV and ICD-10
disorders. The MINI was validated in a cross-national
study involving more than 600 subjects. The concordance
and psychometric values of the MINI Core, as compared
to the CIDI [56] and the SCID-P [57], were found to be
satisfactory. Furthermore, applicants scoring below the
inclusion criteria of depressive and anxiety symptoms will
be excluded, measured by a score of 9 and below on the
Dutch version of the CES-D [48] and a score of 2 and
below on the Dutch version of the HADS-A [49]. In addi-
tion, when applicants started taking anti-depressant med-
ication or benzodiazepines recently (within the previous
2 months) or are currently receiving any psychological
treatment they will be excluded. Finally, people will be
excluded if the health care professionals assess that other
serious psychopathology is present; then they are referred
for psychological treatment. Applicants eligible to partici-
pate will be asked to sign an informed consent form.
Randomization
Participants will be randomly assigned to either the exper-
imental or control condition by means of a centrally con-
ducted randomization process, stratified for gender and
symptom level (no major depressive episode (0–4 symp-
toms) or slight (5 symptoms) to moderate (6–7 symp-
toms) major depressive episode). The randomization will
be conducted at the University of Twente, independent of
the participating mental health care centres. The mental
health care centres and participants receive the outcome
of the randomization by mail.
Experimental condition
In total, 14 Dutch mental health care centres -in both rural
and urban areas- have expressed their agreement to partic-
ipate in this study. The therapists and prevention workers
(from now on called therapists) at these centres -that will
implement "The stories we live by"- all have therapeutic
backgrounds or an education in behavioural sciences
(e.g., psychology) or social work. For the purpose of offer-
ing the intervention they have received a two-day training
program, which was supervised by a psychotherapist spe-
cialized in narrative therapy and a psychologist special-
ized in life-review. During the intervention, they will
participate in two half-day follow-up meetings and a
booster training.
"The three main components in "The stories we live by"
are described below.
The first component is a focus on developing alternative,
more positive, "thicker" life stories. Since the intervention
is aimed at older adults with depressive and anxiety symp-
toms, we expect their stories to contain themes such as
incapacity, disappointment and "being a victim". The
therapists ask questions via deconstruction and recon-
struction, two processes that are central in narrative ther-
apy [58,59,37]. In the deconstruction phase, the
therapists will explore values and norms that are inherent
to the "problem-saturated stories" -and that may be inau-
thentic to the participant-, unique memories that seem to
contradict the dominating problem-orientated story. An
example of a deconstruction question that the therapist
could ask is "Where there any exceptions (e.g. pleasant
moments) in this difficult time of your life?". In the recon-
struction phase, alternative, more authentic stories based
on the participant's strength are constructed and "thick-
ened". Examples of these questions are "How were you
able to cope with this situation?", and "Now, at a much
later date, can you say that you have also learned from
that period in your life, could you explain?".
The second important component of the intervention is
the systematic evaluation of one's life course, with a spe-
cial focus on integrating negative life events with positive
life events within participants' life stories. The interven-
tion places the problems and conflicts that participants
experience in the context of their life course, which
involves making explicit links between the past and the
present. This makes the intervention different from narra-
tive therapy, where there is often much more focus on the
present or themes the client feels like introducing into a
session. During the intervention meetings, participants
have to review their lives. Each intervention meeting has a
different life theme, namely "our origin", "youth", "work
and care", "love and conflicts", "loss and difficult peri-
ods", "metaphor", "the course of life" and "the future".
Before each meeting, participants have to answer ques-
tions about different life themes. At home, they have to
reflect upon these questions and write the responses downBMC Public Health 2009, 9:250 http://www.biomedcentral.com/1471-2458/9/250
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briefly. During the meetings, they have the opportunity to
exchange and discuss the answers and experiences with
the other participants. At home, participants can do crea-
tive assignments, which stimulate the imagination and
may open up new ways of expression besides the verbal
mode. To minimize resistance, we consciously choose to
offer these assignments in a facultative manner. In the
final meetings, attention is focused on the near future, to
invite participants to convert their "new identity" into
concrete actions.
The third important component of the intervention is the
attention for specific positive memories, which are special
and unique for a certain period in the participant's life.
Participants have to write down exactly what they remem-
ber of this situation and describe it by means of the fol-
lowing questions: "Where was it?", "What did the
environment look like?", "Which people where there and
what did everyone look like?", "What happened exactly?".
We expect that especially in depressive and anxious peo-
ple these questions will activate memories that were "for-
gotten". This probably leads to a better balance between
positive and negative memories, in that positive details
are coming to the forefront again.
The intervention is aimed at four to six people and con-
sists of eight similarly structured two-hour sessions. At the
start of the sessions people are asked to explain into two
or three sentences what they have learnt from the previous
session with regard to their lives. Then, participants have
to review their lives and exchange and discuss their expe-
riences with the other participants. Finally, in each session
attention is given to specific positive memories that the
participants come up with.
Control condition
Participants in the control condition receive no interven-
tion. However, they have unrestricted access to care-as-
usual and may receive all health care they desire. Moreo-
ver, participants are not withheld from any treatment (e.g.
they may receive psychological treatment). In the context
of the economic evaluation, health care uptake will be
closely monitored. After conclusion of the RCT, the partic-
ipants in the control condition will be invited to take part
in the intervention.
Measurements
Overview
Table 1 gives an overview of all measurements. Partici-
pants will be asked to complete questionnaires at baseline
(t0), directly after the end of the intervention (t1), 3
months after the end of the intervention (t2), and -only in
the intervention condition- 6 months after the end of the
intervention (t3). The primary and secondary outcome
Table 1: Measurement overview (intake, t0, t1, t2 and t3)
Outcome measure Instrument t0 t1 t2 t3*
Primary outcome measure
Depressive symptoms CES-D X X X X
Secondary outcome measures
Current major depressive episode MINI X X
Anxiety symptoms HADS-A X X X X
Quality of life EQ 5-D X X X X
Positive mental health MHC-SF X X X X
Moderating measures
Demographics (age, gender and education level) X
Personality NEO-FFI X
Past major depressive episodes MINI X
Important life events X
Chronic diseases X
Mediating measures
Reminiscence functions RFS X X X
Perceived control Mastery scale X X X
Automatic positive thoughts ATQ-P X X X
Meaning in life MLQ-SF X X X
Measures for the economic evaluation
Resource use TIC-P X X
Production losses PRODISQ X X
*Only in intervention conditionBMC Public Health 2009, 9:250 http://www.biomedcentral.com/1471-2458/9/250
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measures will be recorded at all measurements (except for
current major depressive episode), moderators only once
at t0, the mediators at t0, t1 and t2 and the measures for
economic evaluation only at t0 and t2.
Primary outcome measure
1.  Depressive symptoms will be measured using the
Dutch version of the CES-D [48].
Secondary outcome measures
2. The presence of anxiety symptoms will be assessed
using the Dutch version of the HADS-A [49].
3. The presence of a current major depressive episode will
be measured using the Dutch version of the MINI
[54,55].
4. Quality of life will be determined using the Dutch
version of the EuroQol (EQ-5D). The EQ-5D is a vali-
dated instrument for measuring health-related quality
of life [60]. It covers five domains of health: mobility,
self-care, usual activity, pain/discomfort and depres-
sion/anxiety. Each of the five domains has three sever-
ity levels; 0 (none), 1 (some) and 2 (severe).
Permutation of the EQ-5D scores generates a total of
243 distinct health states, each of which is associated
with a utility score ranging from 0 (poor health, simi-
lar to death) to 1 (perfect health). These utilities (also
known as "tariffs") have been obtained in the UK and
in the Netherlands [61,62]. In our study, we will use
the Dutch EQ-5D tariffs to compute quality adjusted
life years (QALYs) gained, and these will be used as
outcome for the cost-utility analysis.
5.  Positive mental health will be assessed using the
Dutch version of the Mental Health Continuum Short
Form (MHC-SF) [63]. The MHC-SF measures the men-
tal health that according to Keyes is not simply the
absence of mental illness, but the presence of positive
feelings (emotional well-being) together with positive
functioning in both individual life (psychological
well-being) and community life (social well-being)
[64]. The MHC-SF is a 14-item questionnaire and
measures three dimensions: hedonic well-being (3
items), social well-being (5 items) and psychological
well-being (6 items). Participants are asked how often
they have experienced the feelings described in the
items during the past month, using a 6-point answer
format ranging from "never", "once or twice",
"approximately once a week", "two or three times a
day", "almost every day" to "every day". The MHC-SF
has been shown to have good psychometric properties
[65], also for the Dutch population [66].
Moderating measures
1. The demographics that we will measure are age, gen-
der and level of education.
2. Personality will be assessed using the Dutch version
of the NEO-FFI [67,68]. This self-report questionnaire
consists of 60 statements covering 5 main dimensions
of personality: neuroticism, extraversion, openness to
new experiences, agreeableness, and conscientious-
ness. Each statement is rated on a 5-point scale ranging
from "strongly disagree" to "strongly agree," resulting
in total dimension score between 12 and 60. The
NEO-FFI has good psychometric properties [67,69].
3. Past major depressive episodes will be measured
using the Dutch version of the MINI [54,55].
4. We will ask participants if they have any chronic dis-
orders, such as coronary diseases, lung diseases, or
rheumatism.
5. Participants have to report if any critical life events
had occurred within in the previous three years, such
as the lost of a spouse or a divorce.
Mediating measures
1. Reminiscence functions will be measured using the
Dutch version of the Reminiscence Functions Scale
(RFS), a valid and reliable 43-item questionnaire that
assesses reminiscence functions over one's life course
[70,71]. The scale comprises eight subscales (factors)
reflecting possible functions of reminiscence for the
individual. The subscales are labelled "boredom
reduction", "death preparation", "identity", "prob-
lem-solving", "conversation", "intimacy mainte-
nance", "bitterness revival", and "teach/inform".
Questions typically start with "when I reminiscence, it
is..." and are completed using 43 possible reasons or
motivations to reminiscence. Respondents will be
asked to indicate the extent to which each of the 43
reasons applies to them. Possible answers range from
1 to 6 (never, rarely, seldom, occasionally, often, or
very often). For the purpose of this research, 23 ques-
tions covering four subscales have been selected: 6
about boredom reduction, 6 about identity, 6 about
problem solving, and 5 about bitterness revival. Exam-
ples are: "When I reminisce, it is... to pass the time dur-
ing idle or restless hours" (boredom reduction), "to
see how my past fits in with my journey through life"
(identity), "to help me plan for the future" (problem
solving), or "to keep painful memories alive" (bitter-
ness revival). Scores are averaged per subscale each,
representing a reminiscence function. The higher the
score, the more the indicated function prevails. In
addition, the summary score of all items indicates theBMC Public Health 2009, 9:250 http://www.biomedcentral.com/1471-2458/9/250
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extent to which a person reminiscences, irrespective of
the reason or function of reminiscence.
2. To assess the degree of perceived control over one's
life, we will use the Dutch version of the Mastery Scale
[72]. This consists of seven items that are intended to
assess beliefs about perceived control over one's life in
general or beliefs regarding one's ability to control an
event. We use the abbreviated version of five items
which are each phrased in a negative way. Possible
responses are given on a 5-point scale ranging from 1
"strongly disagree" to 5 "strongly agree". Summary
scores range from 5 to 25. Higher scores on the scale
indicate lower levels of perceived control. The Mas-
tery-Scale has good psychometric properties [72].
3. Automatic positive thoughts will be measured using
the Dutch version of the Automatic Thoughts Ques-
tionnaire Positive (ATQ-P), which asks respondents to
rate how frequently each of the 30 positive self-state-
ments or a similar thought occurred during the preced-
ing week on 5-point scales ranging from 1 (never) to 5
(all the time). The scale's total score represents the
degree of overall positive thinking [73]. The ATQ-P
has good psychometric properties in 257 Dutch
bereaved adults [74].
4. Meaning in life will be measured using the Meaning
in Life Questionnaire (MLQ), a 10-item measure of
the presence of, and the search for, meaning in life
[75]. We will use a Dutch version in which partici-
pants have to answer on a 5-point scale from 1 "abso-
lutely untrue" to 5 "absolutely true" what they think
makes their life feel important to them. The MLQ has
good psychometric properties [75].
Measures for the economic evaluation
The economic evaluation will be carried out using the
Trimbos and Institute of Medical Technology Assessment
Questionnaire on Costs Associated with Psychiatric Ill-
ness (TIC-P), the PROductivity and DISease Question-
naire (PRODISQ), and the EQ-5D. The costs of receiving
formal or informal health care will be measured using the
TIC-P [76]. Costs will be assessed from a societal perspec-
tive and include both direct and indirect costs related to
receiving formal and informal health care. Production
losses due to illness in the four weeks preceding the
research, in terms of both paid and unpaid work, are cov-
ered by the relevant parts of the PRODISQ [77]. These
costs arise when people are absent from work, or work less
efficiently due to depression, for example. A lost working
day will be monetarily valued using the gender and age
specific value of productivity losses, as reported by Oost-
enbrink et al. [78] indexed for the reference year 2007. The
EQ-5D health state valuations correspond with QALYs
gained or lost when each person stays in a particular
health state for precisely one year. For the health state val-
uations we will make use of the Dutch tariffs [62].
Effectiveness analysis of primary and secondary outcome 
measures
To test the null-hypothesis of the intervention's non-infe-
riority relative to care-as-usual, analysis will be conducted
on an intention-to-treat basis following the CONSORT
guidelines [79]. To that end, missing observations at fol-
low-up will be imputed. If there are missing values at dif-
ferent measurements due to drop-out, multiple
imputation (MI) is used to replace the missing values with
ten new estimates. Relative improvements in the clinical
endpoints in the experimental condition as compared to
the care-as-usual control condition will be evaluated with
help of linear modelling (e.g., regression analysis for
Gaussian distributed dependent variables). In linear mod-
elling framework, adjustments for confounders can be
carried out, when so required. In the likely absence of con-
founders, this approach is equivalent to conducting a t-
test of the clinical endpoint on the conditions (coded 1
for the experimental and 0 the control condition). When
the clinical endpoint of interest is not normally distrib-
uted, the test and the 95% confidence intervals will be
based on robust standard errors (i.e., while using the first-
order Taylor-series linearization method) or on non-para-
metric bootstrap techniques (with 2,500 bootstrap repli-
cations). This would help to ascertain the effectiveness of
the treatment relative to the comparator condition.
Power calculation and sample size
To demonstrate presence of an effect of at least 0.35 stand-
ard units, (considered to be the lower-bound of a
medium-sized effect [80]) as statistically significant in a
one-tailed test at alpha = 0.05 and a power of (1-beta) =
0.80 a minimum of 80 participants in each condition will
be required at follow-up (power calculation in Stata 7.0).
Anticipating a drop-out rate of 20% between t0 and t2,
100 participants per condition need to be included at t0.
We will use one-tailed tests in our study, because our
hypotheses are directional. Moreover, a one-tailed test
provides more power to detect an effect and requires a
smaller sample size, which is preferred from a medical-
ethics and financial point of view.
Analysis of moderators
Following Kraemer et al., moderating factors measured at
baseline (t0) will be identified using multivariate regres-
sion analysis of the imputed clinical endpoints (at last fol-
low-up) on the interaction terms of the putative
moderators with the treatment dummy (alongside their
constituent main-effects) [47]. In this way, it can be tested
if some baseline characteristics of the participants are
prognostically favourable (or not) when this particularBMC Public Health 2009, 9:250 http://www.biomedcentral.com/1471-2458/9/250
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intervention is offered. This knowledge may alert us to
possible improvements of the intervention, and should
that prove difficult, then to at least be able to improve
referral of patients to this intervention (i.e., indications
and contra-indications for a more optimal patient – treat-
ment match).
Analysis of mediating measures
Mediating analyses will be performed in accordance with
the steps outlined by Kraemer et al. [47]. In step 1, the
putative mediator (e.g. mastery) will be the dependent
measure and the treatment the independent variable. This
establishes that the intervention is correlated with the
putative mediator. In step 2, the dependent measure will
be the outcome measure (e.g. CES-D and HADS-A). The
independent measures are: treatment (coded 1 for the
experimental and -1 for the control condition, putative
mediator (centred at the average of both conditions), and
the "treatment × putative mediator" interaction. This will
be done to assess whether there is either a main effect of
the putative mediator or an interactive effect with treat-
ment. In this model, the intercept is the mean response to
both conditions. The main effect of treatment equals the
treatment-control difference (i.e., the main effect of the
mediator is the average slope of treatment and control).
Finally, the interactive effect is the difference between the
two slopes.
Economic evaluation
The aim of the economic evaluation is to estimate the
incremental cost-utility in terms of quality-adjusted life
years (QALYs) and the cost-effectiveness in terms of
avoided cases of depression and anxiety in the treatment
condition as compared to the comparator condition. In
addition, costs of the intervention itself will be estimated.
Cost calculations will be conducted following the Nether-
lands guidelines for economic evaluations [78], and will
be carried out from the societal perspective and with the
time-horizon set at one year. Due to this short time-hori-
zon, costs will not be discounted.
Production losses will be valued monetarily with help of
the so called "friction cost" method. Costs and QALYs will
be assessed while employing the intention-to-treatment
method. If clinical and economic end-points are missing
at follow-up, they will be replaced by expected values
(based on MI). In addition, the incremental cost-effective-
ness ratio (ICER) will be calculated, the ratio of the differ-
ence in costs (cost of intervention condition minus cost of
comparator condition) divided by the difference in effects
(effect of intervention condition minus effect of compara-
tor condition) [81]. Its uncertainty will be graphically rep-
resented in the ICER plot with help of the bootstrap
method (with 2,500 bootstrap replications), a statistical
method based on repeatedly sampling from the observed
data generated in an evaluation [82].
Finally, cost-effectiveness acceptability (CEAcc) curves
will be plotted. CEAcc curves are a graphical representa-
tion of the probability that a particular intervention is
cost-effective, over a range of possible values for the max-
imum willingness to pay for a unit improvement in health
outcomes, λ [83]. However, given that the value of λ is
unknown, the probability that the new intervention is rel-
atively more cost-effective than existing practice is pre-
sented for a range of levels of willingness to pay. Thus a
CEAcc curve is created by varying the value of l from zero
to infinity [81]. In our study we ascertain how the likeli-
hood of the intervention being more acceptable from a
health economic point of view depends on the willing-
ness to pay for a QALY. Sensitivity analyses will be carried
out to ascertain the robustness of the findings under dif-
ferent scenarios, e.g. under varying values of the main cost
drivers that represent the most significant expenses.
Discussion
The purpose of this study is to evaluate the effectiveness of
"The stories we live by" intervention, a recently developed
life-review intervention. We predict that the experimental
condition will show superior effects in reducing depres-
sive and anxiety symptoms and in improving quality of
life and positive mental health, and will be cost effective.
Both the intervention itself and its evaluation are likely to
add to the existing body of knowledge in several ways, as
described below.
Strengths and limitations of the life-review intervention
The life-review intervention is unique in linking life-
review with narrative therapy and in its focus on specific
positive memories. An advantage of life-review as an inter-
vention method is that it connects with two activities
often seen in older people: reminiscing and story-telling.
Also, the method seems to suit people who struggle with
identity and meaning-in-life questions, especially when
people are confronted with traumatic or important life-
events or with significant life transitions, which possibly
could lead to confusion, and feelings of hopelessness.
Life-review interventions may help people to come to sto-
ries of their lives and find starting points in their own
experiences that may help to find their own identity.
However, the use of life-review as a method for therapeu-
tic intervention may have limitations. A possible limita-
tion is that participants' bitterness revival and feelings of
victimization may be reinforced. This may happen when
they over and over discuss their negatively coloured story.
At the same time they are not able to distance themselves
from it. When this is the case, the depressive symptoms
exhibited by participants tend to increase, rather thanBMC Public Health 2009, 9:250 http://www.biomedcentral.com/1471-2458/9/250
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decline. Life-review should not to be seen as a harmless
method without the risk of inducing negative effects.
Therefore, it is a priority that the life-review process is
guided by experienced health care professionals. To
ensure this, the therapists participating in our study our
obliged to have a therapeutic background, or an educa-
tion in behavioural sciences (e.g., psychology) or social
work and have received a specific training program before
working with participants. After this training, they are able
to invite the participants -through directed questions- to
come to new life stories and to continuously link the
present with the near future.
Strengths and limitations of the RCT
Our study will answer questions regarding the acceptabil-
ity and effectiveness of life-review that have not been
addressed until now. We will investigate who benefits
most and will try to understand the clinical pathways that
are responsible for inducing the treatment effect. For
example, we have included the role of personality as a
new potential moderator and we have included a meas-
urement scale based on reminiscence styles -the Reminis-
cence Function Scale- to investigate if it functions as a
mediator. In addition, we have added an economic evalu-
ation, and are one of the first to do this regarding life-
review (also in the study protocol by Pot et al. [84]). How-
ever, it should be noted that these additional analyses can-
not be conducted in absence of a treatment effect.
Furthermore, our RCT gives us the opportunity to make
generalizations, as the intervention will be studied in its
natural setting and the recruitment strategy of the study is
very similar to the actual recruitment of the mental health
care centres that will offer "The stories we live by".
Another strength of this RCT is the use the MINI, a struc-
tured diagnostic interview for DSM-IV and ICD-10 psychi-
atric disorders. This allows us to stratify the
randomization by symptom level (no major depressive
episode or slight to moderate major depressive episode)
and to detect any changes in the status of major depressive
episode.
We recognize some limitations in this study. First, the
time available to study a change in the outcome measures
was only six months. For ethical reasons, the participants
in the control condition received the intervention 3
months after t1. For future research an extended period is
advised. Second, there is no control condition at six-
month follow-up after the course. Therefore, definite con-
clusions that the possible effects at six-month follow-up
may be related to the intervention cannot be made. Third,
the extended follow-up period was only nine months fol-
lowing the conclusion of the course, but longer follow-up
periods are needed to investigate for how long the possi-
ble effects will persist.
Notwithstanding the limitations, the development and
research of interventions that prevent depressive and anx-
iety symptoms from developing into full-blown depres-
sion and anxiety is of the utmost importance, as these
severe and persistent mental disorders are associated with
a large burden of disease and extensive economic costs.
Due to the pragmatic nature of the RCT, results will show
whether or not potential effects will hold in mental health
care practice and can be considered ecologically valid.
Presently, Dutch mental health care centres are highly
interested in working with life-review interventions.
Moreover, "The stories we live by" has the potential to be
implemented in several target groups, as the intervention
is for example already offered to Turkish and Moroccan
older people. To conclude, when the hypothesis of the
interventions superiority over care-as-usual can be dem-
onstrated, there will be available a new evidence-based
life-review intervention to alleviate depressive and anxiety
symptoms among people of 55 years and over.
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